Craig Lipset is Director of Health Technologies at Pfizer, working from the company's New York corporate headquarters.

At Pfizer, Craig is responsible for technology-based initiatives spanning clinical and commercial.  Serving as Platform Leader for patient adherence technologies, Craig is working at a transactional as well as strategic level in the appropriate application of technologies to monitor and influence adherence.

Prior to Pfizer, Craig served as Associate Vice President of Program Management at Adnexus Therapeutics (acquired by Bristol-Myers Squibb), where he was responsible for Toxicology, Clinical, and Regulatory.  He served as President of Critical Path Imaging, a consulting firm improving the use of medical imaging in drug development.  Craig was a founding employee of Perceptive Informatics, a clinical technology services and software company (later operating as a subsidiary of Parexel International), where he was Head of Operations and Business Development for the company"s core lab business.

He serves on the editorial board of the Drug Information Journal, and as an advisor to a patient research and advocacy organization.